These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 16095504)

  • 1. Regional variations in peer reviewed liver allocation under the MELD system.
    Rodriguez-Luna H; Vargas HE; Moss A; Reddy KS; Freeman RB; Mulligan D
    Am J Transplant; 2005 Sep; 5(9):2244-7. PubMed ID: 16095504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Center variation in the use of nonstandardized model for end-stage liver disease exception points.
    Goldberg DS; Makar G; Bittermann T; French B
    Liver Transpl; 2013 Dec; 19(12):1330-42. PubMed ID: 24039090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver transplantation for hepatocellular carcinoma: the MELD impact.
    Sharma P; Balan V; Hernandez JL; Harper AM; Edwards EB; Rodriguez-Luna H; Byrne T; Vargas HE; Mulligan D; Rakela J; Wiesner RH
    Liver Transpl; 2004 Jan; 10(1):36-41. PubMed ID: 14755775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exception point applications for 15 points: an unintended consequence of the share 15 policy.
    Bittermann T; Makar G; Goldberg D
    Liver Transpl; 2012 Nov; 18(11):1302-9. PubMed ID: 22899664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience.
    Schaffer RL; Kulkarni S; Harper A; Millis JM; Cronin DC
    Liver Transpl; 2003 Nov; 9(11):1211-5. PubMed ID: 14586883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. United Network for Organ Sharing regional variations in appeal denial rates with non-standard Model for End-Stage Liver Disease/Pediatric End-Stage Liver Disease exceptions: support for a national review board.
    Gish RG; Wong RJ; Honerkamp-Smith G; Xu R; Osorio RW
    Clin Transplant; 2015 Jun; 29(6):513-22. PubMed ID: 25808918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OPTN policy regarding prioritization of patients with hepatopulmonary syndrome: does it provide equitable organ allocation?
    Sulieman BM; Hunsicker LG; Katz DA; Voigt MD
    Am J Transplant; 2008 May; 8(5):954-64. PubMed ID: 18416736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Model for end-stage liver disease exceptions committee activity in Argentina: does it provide justice and equity among adult patients waiting for a liver transplant?
    McCormack L; Gadano A; Lendoire J; Quiñonez E; Imventarza O; Andriani O; Toselli L; Gil O; Gondolesi G; Bisigniano L; De Santibañes E
    HPB (Oxford); 2010 Oct; 12(8):531-7. PubMed ID: 20887320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
    Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
    Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic impact of MELD on liver transplant centers.
    Axelrod DA; Koffron AJ; Baker T; Al-Saden P; Dixler I; McNatt G; Sumner S; Vaci M; Abecassis M
    Am J Transplant; 2005 Sep; 5(9):2297-301. PubMed ID: 16095512
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Korean Liver Allocation System using Model for End Stage Liver Disease Scores: A Nationwide, Multicenter study.
    Lee J; Lee JG; Jung I; Joo DJ; Kim SI; Kim MS;
    Sci Rep; 2019 May; 9(1):7495. PubMed ID: 31097768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved waiting-list outcomes in Argentina after the adoption of a model for end-stage liver disease-based liver allocation policy.
    Cejas NG; Villamil FG; Lendoire JC; Tagliafichi V; Lopez A; Krogh DH; Soratti CA; Bisigniano L
    Liver Transpl; 2013 Jul; 19(7):711-20. PubMed ID: 23775946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allocation of liver grafts worldwide - Is there a best system?
    Tschuor C; Ferrarese A; Kuemmerli C; Dutkowski P; Burra P; Clavien PA;
    J Hepatol; 2019 Oct; 71(4):707-718. PubMed ID: 31199941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of MELD 30-allocation policy on liver transplant outcomes in Italy.
    Ravaioli M; Lai Q; Sessa M; Ghinolfi D; Fallani G; Patrono D; Di Sandro S; Avolio A; Odaldi F; Bronzoni J; Tandoi F; De Carlis R; Pascale MM; Mennini G; Germinario G; Rossi M; Agnes S; De Carlis L; Cescon M; Romagnoli R; De Simone P
    J Hepatol; 2022 Mar; 76(3):619-627. PubMed ID: 34774638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proposal of a novel MELD exception point system for hepatocellular carcinoma based on tumor characteristics and dynamics.
    Bhat M; Ghali P; Dupont B; Hilzenrat R; Tazari M; Roy A; Chaudhury P; Alvarez F; Carrier M; Bilodeau M
    J Hepatol; 2017 Feb; 66(2):374-381. PubMed ID: 27751840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New national liver transplant allocation policy: is the regional review board process fair?
    Voigt MD; Zimmerman B; Katz DA; Rayhill SC
    Liver Transpl; 2004 May; 10(5):666-74. PubMed ID: 15108259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Directed solutions to address differences in access to liver transplantation.
    Ye F; Sheng Q; Feurer ID; Zhao Z; Fan R; Teng J; Ping J; Rega SA; Hanto DW; Shyr Y; Karp SJ
    Am J Transplant; 2018 Nov; 18(11):2670-2678. PubMed ID: 29689125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liver transplantation in the MELD era: a single-center experience.
    Sachdev M; Hernandez JL; Sharma P; Douglas DD; Byrne T; Harrison ME; Mulligan D; Moss A; Reddy K; Vargas HE; Rakela J; Balan V
    Dig Dis Sci; 2006 Jun; 51(6):1070-8. PubMed ID: 16865573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Model for End-stage Liver Disease Score-based Allocation System in Korea: A Nationwide Study.
    Lee J; Kim DG; Lee JY; Lee JG; Joo DJ; Kim SI; Kim MS
    Transplantation; 2019 Dec; 103(12):2515-2522. PubMed ID: 30985735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allocation policy for hepatocellular carcinoma in the MELD era: room for improvement?
    Roayaie K; Feng S
    Liver Transpl; 2007 Nov; 13(11 Suppl 2):S36-43. PubMed ID: 17969067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.